Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire F Friedman

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2024
The Intrauterine Device: How to Deploy This Strategy in the Molecular World?Paul Johannet, Claire F Friedman
Current Oncology Reports|February 29, 2016
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint InhibitionClaire F Friedman, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2022
Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical CancerKathryn M Miller, Claire F Friedman
Current Treatment Options in Oncology|February 9, 2018
Options for Adjuvant Therapy for Uterine LeiomyosarcomaClaire F Friedman, Martee L Hensley
Journal of Geriatric Oncology|May 17, 2017
Checkpoint inhibition and melanoma: Considerations in treating the older adultClaire F Friedman, Jedd D Wolchok
Trends in Immunology|May 10, 2016
Patient-Physician Communication in the 21st CenturyClaire F Friedman, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2023
The Search for Genomic Biomarkers of Response to Immunotherapy in Ovarian CancerDuaa H Al-Rawi, Nicole Rusk, Claire F Friedman
Advances in Immunology|March 1, 2016
Combinatorial Cancer ImmunotherapiesMatthew D Hellmann, Claire F Friedman, Jedd D Wolchok
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Locally Advanced Cervical Cancer: What is the Preferred Systemic Treatment?Matthew L Flint, Maureen E Byrne, Claire F Friedman
JAMA Oncology|July 2, 2016
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A ReviewClaire F Friedman, Tracy A Proverbs-Singh, Michael A Postow
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2024
The Intrauterine Device: How to Deploy This Strategy in the Molecular World?Paul Johannet, Claire F Friedman
Current Oncology Reports|February 29, 2016
Emerging Tissue and Blood-Based Biomarkers that may Predict Response to Immune Checkpoint InhibitionClaire F Friedman, Michael A Postow
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 10, 2022
Bifunctional Blockade: A Novel Immunotherapy Approach for Cervical CancerKathryn M Miller, Claire F Friedman
Current Treatment Options in Oncology|February 9, 2018
Options for Adjuvant Therapy for Uterine LeiomyosarcomaClaire F Friedman, Martee L Hensley
Journal of Geriatric Oncology|May 17, 2017
Checkpoint inhibition and melanoma: Considerations in treating the older adultClaire F Friedman, Jedd D Wolchok
Trends in Immunology|May 10, 2016
Patient-Physician Communication in the 21st CenturyClaire F Friedman, Jedd D Wolchok
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2023
The Search for Genomic Biomarkers of Response to Immunotherapy in Ovarian CancerDuaa H Al-Rawi, Nicole Rusk, Claire F Friedman
Advances in Immunology|March 1, 2016
Combinatorial Cancer ImmunotherapiesMatthew D Hellmann, Claire F Friedman, Jedd D Wolchok
Journal of the National Comprehensive Cancer Network : JNCCN|February 11, 2026
Locally Advanced Cervical Cancer: What is the Preferred Systemic Treatment?Matthew L Flint, Maureen E Byrne, Claire F Friedman
JAMA Oncology|July 2, 2016
Treatment of the Immune-Related Adverse Effects of Immune Checkpoint Inhibitors: A ReviewClaire F Friedman, Tracy A Proverbs-Singh, Michael A Postow
Pageof 6